CT

Craig Thompson

Chief Executive Officer

Cerevance

San Diego, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Cerevance
Industry
research
Employees
57.0
Seniority
C suite
Annual Revenue
7800000.0
Total Funding
2024500000.0
Latest Funding
Series B

Technologies

Outlook Amazon AWS Cedexis Radar Vimeo Google Font API Mobile Friendly Google Tag Manager Adobe Media Optimizer Render AI Data Analytics

Keywords

biotechnology research cns disorders neurodegenerative diseases parkinson's disease alzheimer's disease amyotrophic lateral sclerosis neuroinflammation clinical trials neuropsychiatric disorders drug discovery netsseq target identification oral therapies disease modification dopaminergic therapies non-dopaminergic drugs specific gene targeting gpr6 inverse agonist off time reduction patient enrollment phase 1 studies phase 2 studies phase 3 studies dysfunction management therapeutic development biopharmaceutical stages symptom management clinical research molecular profiling brain tissue analysis multi-omics data neuroscience innovations molecular changes snp connections advanced therapeutics psychiatric conditions biotechnology selective target modulation biotech partnerships biomarker studies pharmaceutical funding transformative therapies motor function improvement neuroanatomy clinical data presentation clinical outcomes research collaborations biological mechanisms therapeutic development pipeline disease progression understanding health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans